Center for Biologics Evaluation and Research
Encyclopedia : C : CE : CEN : Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research (CBER) is one of five main centers for the Food and Drug Administration, which is in the United States Department of Health and Human Services. CBER is responsible for assuring the safety, purity, potency, and effectiveness of biological products such as:
- Blood and blood products.
- Cells and tissues for transplant.
- Vaccines.
- Gene therapy.CBER websit, CBER's Vision and Mission: [link]
Authority
As of July 2006 CBER's authority resides in section 351 of the Public Health Service Act and in various sections of the Food, Drug and Cosmetic Act.CBER website, About CBER:[link]At the CBER's Vaccines and Related Biological Products Advisory Committee's 101st meeting of February 16, 2005, an extensive discussion and vote was held concerning next year's flu vaccine virus selection. (transcript of U.S. FDA Center for Biologics Evaluation and Research Vaccines and Related Biological Products Advisory Committee's 101st meeting of February 16, 2005 is here: [origin.www.fda.gov in .DOC format] [in Google provided HTML format])
Further reading
Sources
| Vaccination/Vaccine (and Immunization, Inoculation. See also List of vaccine topics and Epidemiology) |
| Development: Models - Timeline - Toxoid - Trial Administration: ACIP - GAVI - VAERS - Vaccination schedule - VSD Specific vaccines: Anthrax - BCG - Cancer - DPT - Flu - HIV - HPV - MMR - Pneumonia - Polio - Smallpox Controversy: A-CHAMP - Anti-vaccinationists - NCVIA - Pox party - Safe Minds - Simpsonwood - Thimerosal controversy - Vaccine injury |
From Wikipedia, the Free Encyclopedia. Original article here. Support Wikipedia by contributing or donating.
All text is available under the terms of the GNU Free Documentation License See Wikipedia Copyrights for details.